|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$7.33 |
$8.06 |
$7.17 |
$8.02 |
528.30K | 03/25/2024 |
$8.01 |
$8.42 |
$7.70 |
$7.93 |
397.30K | 03/26/2024 |
$8.02 |
$8.23 |
$7.91 |
$7.99 |
226.60K | 03/27/2024 |
$8.11 |
$9.00 |
$7.97 |
$8.30 |
449.00K | 03/28/2024 |
$8.27 |
$8.29 |
$7.28 |
$7.94 |
741.70K |
|
TScan Therapeutics is a clinical-stage biopharmaceutical company focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. Co.'s proprietary platform is designed to: discover anti-cancer TCRs from patients with exceptional responses to immunotherapy; discover TCRs that recognize clinically validated targets; identify off-targets of TCRs to eliminate candidates; and manufacture TCR-T therapies using Co.'s T-Integrate technology. The central elements of Co.'s platform that differentiate it from other cell therapy companies are TargetScan, ReceptorScan, SafetyScan, ImmunoBank and T-Integrate. | |
|
TScan Therapeutics (TCRX) has the following price history information. Looking back at TCRX historical stock prices for the last five trading days, on March 22, 2024, TCRX opened at $7.33, traded as high as $8.06 and as low as $7.17, and closed at $8.02. Trading volume was a total of 528.30K shares. On March 25, 2024, TCRX opened at $8.01, traded as high as $8.42 and as low as $7.70, and closed at $7.93. Trading volume was a total of 397.30K shares. On March 26, 2024, TCRX opened at $8.02, traded as high as $8.23 and as low as $7.91, and closed at $7.99. Trading volume was a total of 226.60K shares. On March 27, 2024, TCRX opened at $8.11, traded as high as $9.00 and as low as $7.97, and closed at $8.30. Trading volume was a total of 449.00K shares. On March 28, 2024, TCRX opened at $8.27, traded as high as $8.29 and as low as $7.28, and closed at $7.94. Trading volume was a total of 741.70K shares.
TCRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TScan Therapeutics shares, starting with a $10,000 purchase of TCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/19/2021 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$10.01 |
|
End price/share: |
$7.94 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-20.68% |
|
Average Annual Total Return: |
-8.24% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,932.68 |
|
Years: |
2.69 |
|
|
|
Date |
Close |
03/22/2024 | $8.02 | 03/25/2024 | $7.93 | 03/26/2024 | $7.99 | 03/27/2024 | $8.30 | 03/28/2024 | $7.94 |
|
|